These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10642504

  • 1. Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential.
    Cloos PA, Fledelius C.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):473-80. PubMed ID: 10642504
    [Abstract] [Full Text] [Related]

  • 2. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA, Fledelius C, Christgau S, Christiansen C, Engsig M, Delmas P, Body JJ, Garnero P.
    Calcif Tissue Int; 2003 Jan 01; 72(1):8-17. PubMed ID: 12384813
    [Abstract] [Full Text] [Related]

  • 3. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD.
    J Bone Miner Res; 2002 May 01; 17(5):826-33. PubMed ID: 12009013
    [Abstract] [Full Text] [Related]

  • 4. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr 01; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 5. Racemization and isomerization of type I collagen C-telopeptides in human bone and soft tissues: assessment of tissue turnover.
    Gineyts E, Cloos PA, Borel O, Grimaud L, Delmas PD, Garnero P.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):481-5. PubMed ID: 10642505
    [Abstract] [Full Text] [Related]

  • 6. Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone.
    Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD.
    J Bone Miner Res; 1997 Sep 01; 12(9):1407-15. PubMed ID: 9286756
    [Abstract] [Full Text] [Related]

  • 7. Isoaspartyl bond formation within N-terminal sequences of collagen type I: implications for their use as markers of collagen degradation.
    Brady JD, Ju J, Robins SP.
    Clin Sci (Lond); 1999 Feb 01; 96(2):209-15. PubMed ID: 9918902
    [Abstract] [Full Text] [Related]

  • 8. An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.
    Cloos PA, Lyubimova N, Solberg H, Qvist P, Christiansen C, Byrjalsen I, Christgau S.
    Clin Lab; 2004 Feb 01; 50(5-6):279-89. PubMed ID: 15209436
    [Abstract] [Full Text] [Related]

  • 9. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb 01; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 10. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
    Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Echevarría M, Ros I, Ballesta AM, Muñoz-Gómez J.
    J Bone Miner Metab; 2002 Feb 01; 20(2):116-20. PubMed ID: 11862534
    [Abstract] [Full Text] [Related]

  • 11. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS.
    Res Vet Sci; 2004 Aug 01; 77(1):29-39. PubMed ID: 15120950
    [Abstract] [Full Text] [Related]

  • 12. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
    Bonde M, Garnero P, Fledelius C, Qvist P, Delmas PD, Christiansen C.
    J Bone Miner Res; 1997 Jul 01; 12(7):1028-34. PubMed ID: 9200001
    [Abstract] [Full Text] [Related]

  • 13. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr 01; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 14. Characterization of aged osteocalcin fragments derived from bone resorption.
    Cloos PA, Christgau S.
    Clin Lab; 2004 Apr 01; 50(9-10):585-98. PubMed ID: 15481635
    [Abstract] [Full Text] [Related]

  • 15. Localization of biologically uncommon D-beta-aspartate-containing alphaA-crystallin in human eye lens.
    Fujii N, Shimo-Oka T, Ogiso M, Momose Y, Kodama T, Kodama M, Akaboshi M.
    Mol Vis; 2000 Feb 21; 6():1-5. PubMed ID: 10706893
    [Abstract] [Full Text] [Related]

  • 16. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 17. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P, Gineyts E, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Sep 15; 79(3):780-5. PubMed ID: 8077361
    [Abstract] [Full Text] [Related]

  • 18. Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations.
    Garnero P, Schott AM, Prockop D, Chevrel G.
    Bone; 2009 Mar 15; 44(3):461-6. PubMed ID: 19071236
    [Abstract] [Full Text] [Related]

  • 19. Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments.
    Cloos PA, Christgau S, Lyubimova N, Body JJ, Qvist P, Christiansen C.
    Breast Cancer Res; 2003 Mar 15; 5(4):R103-9. PubMed ID: 12818000
    [Abstract] [Full Text] [Related]

  • 20. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
    Fledelius C, Johnsen AH, Cloos PA, Bonde M, Qvist P.
    J Biol Chem; 1997 Apr 11; 272(15):9755-63. PubMed ID: 9092508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.